{
    "Trade/Device Name(s)": [
        "skyla Hi Hemoglobin A1c System",
        "skyla Hi Analyzer",
        "skyla Hi Hemoglobin A1c Reagent Kit"
    ],
    "Submitter Information": "Skyla Corporation Hsinchu Science Park Branch",
    "510(k) Number": "K173127",
    "Predicate Device Reference 510(k) Number(s)": [
        "K151809"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCP",
        "JJE"
    ],
    "Summary Letter Date": "September 25, 2018",
    "Summary Letter Received Date": "August 22, 2018",
    "Submission Date": "August 10, 2018",
    "Regulation Number(s)": [
        "21 CFR 864.7470",
        "21 CFR 862.2160"
    ],
    "Regulation Name(s)": [
        "Glycosylated hemoglobin assay",
        "Discrete photometric chemistry analyzer for clinical use"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "hematology",
        "POCT"
    ],
    "Analyte(s)": [
        "Glycated hemoglobin (HbA1c)"
    ],
    "Specimen Type(s)": [
        "Venous whole blood",
        "Finger-stick capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "skyla Hi Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Immunoturbidimetric assay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Analyzer",
        "Reagent Kit"
    ],
    "Document Summary": "FDA 510(k) summary for the skyla Hi Hemoglobin A1c System, an in-vitro diagnostic system using an immunoturbidimetric assay to measure HbA1c in whole blood.",
    "Indications for Use Summary": "Quantitative measurement of percent concentration of glycated hemoglobin (HbA1c %) in venous and finger-stick capillary whole blood to monitor long-term glycemic control in persons with diagnosed diabetes mellitus; not for screening or diagnosis of diabetes.",
    "fda_folder": "Hematology"
}